Skip to main content
Glama

List Subscriptions

list_subscriptions
Read-onlyIdempotent

List the caller's active subscriptions. Returns id, type, params, created_at, last_fired_at, fire_count for each. Use this to review what you're monitoring before adding more or to find an id to cancel.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
include_inactiveNoInclude cancelled subscriptions in the response (default false).

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Added

TDQS

A4.3/5.0
Behavior3/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already provide readOnlyHint, idempotentHint, destructiveHint. Description adds return field details but no extra behavioral traits beyond annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness5/5

Is the description appropriately sized, front-loaded, and free of redundancy?

Three sentences, front-loaded with purpose and return fields, usage guidance included. No extraneous content.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Simple tool with one optional parameter, return fields listed, annotations cover safety. Description is complete for the complexity.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters3/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100% with a single boolean parameter description. Description does not add meaning beyond schema.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states the tool lists the caller's active subscriptions and specifies return fields. It distinguishes from siblings like subscribe and unsubscribe.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

Explicit guidance: use to review monitoring before adding more or to find an id to cancel. Implies when not to use.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A4.1/5.0
Disambiguation5/5

Every tool has a clearly distinct purpose, even within the same domain (e.g., ask_pipeworx vs ask_pipeworx_grounded vs ask_pipeworx_beta are differentiated by groundedness/beta status; polymarket_edges vs polymarket_arbitrage vs polymarket_fill_risk each target discovery vs arbitrage vs execution risk). The descriptions are highly detailed, eliminating ambiguity about when to use each.

Naming Consistency4/5

All tool names use snake_case consistently, and most follow a verb-first pattern (ask_, compare_, discover_, search_, validate_), but a few are noun-first (entity_profile, polymarket_edges, recent_alerts). The style is readable and predictable, though not perfectly uniform in the verb_noun convention.

Tool Count2/5

With 37 tools, the server is heavily over-scoped, especially given the 'Pharma Intel' name that suggests a focused pharma domain. Many tools are general-purpose (prediction markets, memory, subscription management, feedback) unrelated to the server's apparent purpose, making it feel like a grab bag rather than a cohesive set.

Completeness4/5

The pharma-specific tools cover drug profiles, safety, pipeline scans, catalysts, indication landscapes, and sponsor diligence – a solid lifecycle coverage. The broader data/query/prediction-market tools also feel complete for their respective sub-domains. The only minor gaps are niche operations (e.g., updating a subscription), but these are not critical to the core workflows.

Resources